News from Portfolio Companies

New Ventures News and Publications

  • Illumina’s Phil Febbo on Sequencing, Coronavirus and Viral Outbreaks
    Episode Summary As the Wuhan coronavirus outbreak spreads in Asia, Harry speaks with Phil Febbo, the chief medical officer of Illumina, one of the world’s largest makers of equipment for high-throughput DNA sequencing. Febbo highlights sequencing’s emerging contribution to the understanding and treatment of infectious disease. Episode Notes Rapid sequencing of viral genomes is giving physicians and epidemiologists new ways ...
  • Daniella Gilboa on How Deep Learning Can Revolutionize IVF
    Episode Summary: Daniella Gilboa is an embryologist in Israel working to bring the power of AI and machine learning to the embryo selection phase of IVF treatment. She explains how her new startup aims to automate this error-ridden process, raising efficiency and lowering the overall cost of IVF. Episode Notes: Doctors helping couples conceive through in-vitro fertilization typically must screen ...
  • Drug developers take fresh aim at ‘guided-missile’ cancer drugs
    John Miller Ludwig Burger Published: Jan 06 at 11:08 a.m. By Ludwig Burger and John Miller FRANKFURT/ZURICH (Reuters) – Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an approach that has long fallen short of its promise, an analysis compiled for Reuters shows. ...
  • Tom Davenport on the Analytics Gap in Healthcare
    Episode Summary Harry’s guest this week is Tom Davenport, who argues that the healthcare industry is way behind in its use of big-data analytics software to make smarter decisions about business and patient care. “This is a period of lots of opportunity to use new technologies to change healthcare, and God knows we need it, from a value-for-expense standpoint,” Davenport ...
  • Milind Kamkolkar on Seeing the Forest and the Trees at Cellarity
    Episode Summary: Harry welcomes Milind Kamkolkar back to the program. The former Sanofi exec is now the chief data and digital officer at Cellarity, a Flagship Pioneering-backed therapeutics startup working to model cell behavior computationally in order to identify new drug targets and therapies. Episode Notes: Milind Kamkolkar joined Cellarity in January 2019 to help the company to prove that ...
  • Alan Copperman on How Data is Transforming Reproductive Medicine
    Episode Summary This week Harry welcomes a guest who could be considered a “poster child” for the movement to incorporate more data into clinical practice: Dr. Alan Copperman, a New York-based specialist in reproductive medicine. He says the data generated by genetic screening of fertilized embryos is rapidly and dramatically improving outcomes for couples who want children. Episode Notes Dr. ...
  • Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery
    Episode Summary This week Harry talks with Gini Deshpande, the co-founder and CEO of San Mateo, CA-based NuMedii, a company making judicious use of big data and AI to speed up drug discovery. Episode Notes Gini Desphande says she likes to think of “AI” as augmented intelligence rather than artificial intelligence: a system of human plus machine intelligence that can ...
  • Chris Boone of Pfizer on Being a Data Hippie
    Episode Summary This week Harry talks with Chris Boone, a leader of Pfizer’s effort to use new types of real-world data on patients—from insurance claims to lab tests to molecular profiles to data from wearable health sensor—to speed up drug discovery, development, and testing. Episode Notes Dr. Chris Boone, vice president and lead for global medical epidemiology and big data ...
  • ADC THERAPEUTICS FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING
    Lausanne, Switzerland — September 6, 2019 — ADC Therapeutics SA, a clinical-stage oncology-focused biotechnology company pioneering the development of highly potent and targeted antibody drug conjugates for patients suffering from hematological malignancies and solid tumors, announced today that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public ...
  • Kevin Tabb of Beth Israel Lahey Health on How to Get Ahead of Change in Healthcare
    EPISODE SUMMARY Harry talks with the CEO and president of Beth Israel Lahey Health, the product of Lahey Health’s merger this spring with Beth Israel Deaconess Medical Center and several other hospitals in the Boston region. How does Dr. Tabb manage change inside a growing organization that—by his own admission—has to build and implement new tools, processes and the actionable ...